Completed NA INTERVENTIONAL 3-arm NCT03916341

Smoking and Ventricular Repolarization

Sponsor: Tobacco Related Disease Research Program

Conditions Prolonged QTc Interval Sudden Cardiac Death

Interventions EC with nicotine EC without nicotine TC with nicotine (own brand) control research TC with very low level nicotine

Updated 9 times since 2019 Last updated: Oct 2, 2023 Started: Oct 1, 2019 Primary completion: Apr 10, 2023 Completion: Apr 10, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Prolonged QTc Interval and Sudden Cardiac Death and is currently completed. Tobacco Related Disease Research Program leads this study, which shows 9 recorded versions since 2019 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Nov 2023 — Jul 2024 [monthly]

Completed NA

Status: Recruiting → Completed
Sep 2022 — Nov 2023 [monthly]

Recruiting NA
Jan 2022 — Sep 2022 [monthly]

Recruiting NA

▶ Show 4 earlier versions

Jan 2021 — Jan 2022 [monthly]

Recruiting NA
Apr 2020 — Jan 2021 [monthly]

Recruiting NA
Aug 2019 — Apr 2020 [monthly]

Recruiting NA
May 2019 — Aug 2019 [monthly]

Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Tobacco Related Disease Research Program
University of California, Los Angeles

Data source: University of California, Los Angeles

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Los Angeles, United States